ACM
INDV icon

Aquatic Capital Management’s Indivior Pharmaceuticals INDV Stock Holding History

Aquatic Capital Management’s Portfolio INDV Stock Details INDV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.01M Buy
+122,213
New +$4.43M 0.17% 144
2026
Q1 		– Sell
-37,702
Closed -$1.35M – 1592
2025
Q4 		$1.35M Buy
37,702
+33,373
+771% +$1.02M 0.04% 472
2025
Q3 		$104K Buy
+4,329
New +$90.6K ﹤0.01% 1208

Other funds holding INDV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
OCM
Oaktree Capital Management Los Angeles, California $7.21B AUM 45.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Aquatic Capital Management's INDV Position: Q2 2026 in Review

Aquatic Capital Management opened a new position in Indivior Pharmaceuticals (INDV) in Q2 2026: 122,213 shares worth $5.01M. The stake represents 0.17% of the portfolio and ranks #144 among its holdings. This is a return to the name: Aquatic Capital Management previously reported a position in INDV as recently as Q4 2025.

Aquatic Capital Management first reported a position in INDV in Q3 2025 and has held it in 3 quarters since. 338 funds tracked by Wall St. Rank hold INDV as of Q2 2026.

  • Aquatic Capital Management held 122,213 shares of Indivior Pharmaceuticals worth $5.01M as of Q2 2026.
  • Indivior Pharmaceuticals was a new Aquatic Capital Management position in Q2 2026.
  • Indivior Pharmaceuticals made up 0.17% of Aquatic Capital Management's portfolio in Q2 2026, its #144 holding.
  • Aquatic Capital Management first reported a position in Indivior Pharmaceuticals in Q3 2025 and has held it in 3 quarters since.
  • 338 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q2 2026.

Based on Aquatic Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.